Categories: News

Coloplast A/S – Q1 2023/24 Earnings Release – Invitation for conference call on 9 February 2024 at 11.00am CET

Friday, 9 February 2024 at 11.00 – 12.00 CET
In connection with the publication of Coloplast’s interim financial results for Q1 2023/24, to be released same day around 07.30 am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.

Coloplast will be represented by:
Kristian Villumsen – President & CEO
Anders Lonning-Skovgaard  Executive Vice President, CFO
Aleksandra Dimovska – Senior Director, Investor Relations
Kristine Husted Munk – Senior Manager, Investor Relations

Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here


Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here

 

For more information, please contact:

Aleksandra Dimovska – Senior Director, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com

Kristine Husted Munk – Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3266. E-mail: dkkhu@coloplast.com

Hannah K. Larsen – Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3616. E-mail: dkhakl@coloplast.com

 

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment

Staff

Recent Posts

Apollo Neuroscience Announces 2025 Year in Review

Community Gains Nearly 144 Million Minutes of Sleep, Wins Best Sleep Wearable of 2025NEW YORK,…

3 hours ago

Paytient Recognized by Modern Healthcare for Transforming Patient Experience

COLUMBIA, Mo., Jan. 30, 2026 /PRNewswire/ -- Paytient, a leader in innovative healthcare affordability and…

3 hours ago

Promino Announces Closing of Private Placement

Burlington, Ontario--(Newsfile Corp. - January 30, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC:…

7 hours ago

NuGen Medical Devices Inc. Announces CFO Transition

Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

9 hours ago

Midmark RTLS launches BLE Sensory Network for smarter, scalable RTLS

New Plug-In BLE Sensors provide a faster, more cost-effective path to facility-wide RTLS coverage with near-room…

9 hours ago

Vrtly, Inc. Unveils End-to-End In-Practice Marketing Platform, Bridging the “Blind Spot” for Brands in Cash-Pay Healthcare

DANVILLE, Calif., Jan. 30, 2026 /PRNewswire/ -- Vrtly, Inc., the premier point-of-care (POC) marketing platform…

9 hours ago